A new study—which builds on previous research by Craig Atwood, PhD, professor, Geriatrics and Gerontology—seeks to determine whether the injectable medication leuprolide is able to slow or prevent cognitive decline in women.

“[Leuprolide] is already widely available and relatively inexpensive,” says Dr. Atwood. “If this trial can demonstrate that [it] is effective in treating Alzheimer’s disease, we have the potential to help millions of people avoid the rapid mental decline and devastating impacts of this disease.”

The study is led by a team at Weill Cornell Medical Center in New York and is centered around clinical trials currently enrolling at the University of Wisconsin School of Medicine and Public Health (UW SMPH) and the University of Miami, Florida. 

Read the full story at UW SMPH.

Banner: Craig Atwood, PhD, professor, Geriatrics and Gerontology, in his lab. Credit: Clint Thayer/Department of Medicine.